Copyright Reports & Markets. All rights reserved.

Global Amisulpride Tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Amisulpride Tablets Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 100mg
    • 1.3.3 200mg
    • 1.3.4 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Amisulpride Tablets Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Others
  • 1.5 Global Amisulpride Tablets Market Size & Forecast
    • 1.5.1 Global Amisulpride Tablets Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Amisulpride Tablets Sales Quantity (2021-2032)
    • 1.5.3 Global Amisulpride Tablets Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Sanofi
    • 2.1.1 Sanofi Details
    • 2.1.2 Sanofi Major Business
    • 2.1.3 Sanofi Amisulpride Tablets Product and Services
    • 2.1.4 Sanofi Amisulpride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Sanofi Recent Developments/Updates
  • 2.2 Qilu pharmaceutical
    • 2.2.1 Qilu pharmaceutical Details
    • 2.2.2 Qilu pharmaceutical Major Business
    • 2.2.3 Qilu pharmaceutical Amisulpride Tablets Product and Services
    • 2.2.4 Qilu pharmaceutical Amisulpride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Qilu pharmaceutical Recent Developments/Updates
  • 2.3 Jewim Pharmaceutical
    • 2.3.1 Jewim Pharmaceutical Details
    • 2.3.2 Jewim Pharmaceutical Major Business
    • 2.3.3 Jewim Pharmaceutical Amisulpride Tablets Product and Services
    • 2.3.4 Jewim Pharmaceutical Amisulpride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Jewim Pharmaceutical Recent Developments/Updates
  • 2.4 Zhejiang Huahai Pharmaceutical
    • 2.4.1 Zhejiang Huahai Pharmaceutical Details
    • 2.4.2 Zhejiang Huahai Pharmaceutical Major Business
    • 2.4.3 Zhejiang Huahai Pharmaceutical Amisulpride Tablets Product and Services
    • 2.4.4 Zhejiang Huahai Pharmaceutical Amisulpride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Amisulpride Tablets by Manufacturer

  • 3.1 Global Amisulpride Tablets Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Amisulpride Tablets Revenue by Manufacturer (2021-2026)
  • 3.3 Global Amisulpride Tablets Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Amisulpride Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Amisulpride Tablets Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Amisulpride Tablets Manufacturer Market Share in 2025
  • 3.5 Amisulpride Tablets Market: Overall Company Footprint Analysis
    • 3.5.1 Amisulpride Tablets Market: Region Footprint
    • 3.5.2 Amisulpride Tablets Market: Company Product Type Footprint
    • 3.5.3 Amisulpride Tablets Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Amisulpride Tablets Market Size by Region
    • 4.1.1 Global Amisulpride Tablets Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Amisulpride Tablets Consumption Value by Region (2021-2032)
    • 4.1.3 Global Amisulpride Tablets Average Price by Region (2021-2032)
  • 4.2 North America Amisulpride Tablets Consumption Value (2021-2032)
  • 4.3 Europe Amisulpride Tablets Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Amisulpride Tablets Consumption Value (2021-2032)
  • 4.5 South America Amisulpride Tablets Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Amisulpride Tablets Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Amisulpride Tablets Sales Quantity by Type (2021-2032)
  • 5.2 Global Amisulpride Tablets Consumption Value by Type (2021-2032)
  • 5.3 Global Amisulpride Tablets Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Amisulpride Tablets Sales Quantity by Application (2021-2032)
  • 6.2 Global Amisulpride Tablets Consumption Value by Application (2021-2032)
  • 6.3 Global Amisulpride Tablets Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Amisulpride Tablets Sales Quantity by Type (2021-2032)
  • 7.2 North America Amisulpride Tablets Sales Quantity by Application (2021-2032)
  • 7.3 North America Amisulpride Tablets Market Size by Country
    • 7.3.1 North America Amisulpride Tablets Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Amisulpride Tablets Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Amisulpride Tablets Sales Quantity by Type (2021-2032)
  • 8.2 Europe Amisulpride Tablets Sales Quantity by Application (2021-2032)
  • 8.3 Europe Amisulpride Tablets Market Size by Country
    • 8.3.1 Europe Amisulpride Tablets Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Amisulpride Tablets Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Amisulpride Tablets Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Amisulpride Tablets Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Amisulpride Tablets Market Size by Region
    • 9.3.1 Asia-Pacific Amisulpride Tablets Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Amisulpride Tablets Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Amisulpride Tablets Sales Quantity by Type (2021-2032)
  • 10.2 South America Amisulpride Tablets Sales Quantity by Application (2021-2032)
  • 10.3 South America Amisulpride Tablets Market Size by Country
    • 10.3.1 South America Amisulpride Tablets Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Amisulpride Tablets Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Amisulpride Tablets Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Amisulpride Tablets Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Amisulpride Tablets Market Size by Country
    • 11.3.1 Middle East & Africa Amisulpride Tablets Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Amisulpride Tablets Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Amisulpride Tablets Market Drivers
  • 12.2 Amisulpride Tablets Market Restraints
  • 12.3 Amisulpride Tablets Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Amisulpride Tablets and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Amisulpride Tablets
  • 13.3 Amisulpride Tablets Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Amisulpride Tablets Typical Distributors
  • 14.3 Amisulpride Tablets Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Amisulpride Tablets market size was valued at US$ 115 million in 2025 and is forecast to a readjusted size of US$ 145 million by 2032 with a CAGR of 3.4% during review period.
    Amisulpride is a dopamine D2 receptor antagonist used in the treatment of acute and chronic schizophrenia, and in the prevention and treatment of postoperative nausea and vomiting in adults.
    This report is a detailed and comprehensive analysis for global Amisulpride Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Amisulpride Tablets market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Amisulpride Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Amisulpride Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Amisulpride Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Amisulpride Tablets
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Amisulpride Tablets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, Qilu pharmaceutical, Jewim Pharmaceutical, Zhejiang Huahai Pharmaceutical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Amisulpride Tablets market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    100mg
    200mg
    Others
    Market segment by Application
    Hospital
    Clinic
    Others
    Major players covered
    Sanofi
    Qilu pharmaceutical
    Jewim Pharmaceutical
    Zhejiang Huahai Pharmaceutical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Amisulpride Tablets product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Amisulpride Tablets, with price, sales quantity, revenue, and global market share of Amisulpride Tablets from 2021 to 2026.
    Chapter 3, the Amisulpride Tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Amisulpride Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Amisulpride Tablets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Amisulpride Tablets.
    Chapter 14 and 15, to describe Amisulpride Tablets sales channel, distributors, customers, research findings and conclusion.

    Buy now